title: Long-term cardiac sequelae after treatment of malignant tumors with radiotherapy or cytostatics in childhood.
abstract: A series of 41 individuals were restudied after childhood cancer with a median follow-up time of 17 years after chest irradiation or treatment with cyclophosphamide or Adriamycin (doxorubicin). Radiotherapy of the chest had been used in 21 patients, and in 13 of these irradiation was also directed at the heart. Thirty-five patients received cyclophosphamide and five received Adriamycin therapy. All patients were investigated by a pediatric cardiologist. Investigations included an electrocardiogram (ECG), a chest radiographic film, an echocardiogram, an exercise test, and a 24-hour ECG. Altogether 20 patients (49%) showed some abnormality in cardiac tests. Each additional year of follow-up was associated with a 1.3-fold (95% confidence limits, 1.04-1.66; P less than 0.05) increase in the risk for pathologic cardiac findings. The risk for an abnormal cardiac test result in the 13 patients who had received cardiac irradiation was 12.8-fold (95% confidence limits, 1.8-90.8; P less than 0.02) that of the other patients. However, abnormalities in cardiac function were mild.
authors.affiliation: Children's Hospital, University of Helsinki Medical School, Finland.
authors.forename: L
authors.initials: L
authors.lastname: Mäkinen
authors.forename: A
authors.initials: A
authors.lastname: Mäkipernaa
authors.forename: J
authors.initials: J
authors.lastname: Rautonen
authors.forename: M
authors.initials: M
authors.lastname: Heino
authors.forename: S
authors.initials: S
authors.lastname: Pyrhönen
authors.forename: L A
authors.initials: LA
authors.lastname: Laitinen
authors.forename: M A
authors.initials: MA
authors.lastname: Siimes
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006321:Heart / Q000187:drug effects / Q000503:physiopathology* / Q000528:radiation effects; D006331:Heart Diseases / Q000209:etiology; D006334:Heart Function Tests; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011878:Radiotherapy / Q000009:adverse effects*; D011879:Radiotherapy Dosage; D013997:Time Factors
chemical_list: D004317:Doxorubicin; D003520:Cyclophosphamide